Forward Pharma Cash Flow - Quarterly (NASDAQ:FWP)

Add to My Stocks
$2.59 $0.2 (7.17%) FWP stock closing price Sep 18, 2018 (Closing)

For analyzing any company like Forward Pharma from an investment perspective, its important to check the cash flow statement. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about Forward Pharma profits and Forward Pharma debt. Forward Pharma had cash and cash equivalents of $52.26M at beginning of the quarter and $109.55M at quarter end of 2017 Q4. Forward Pharma cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. Forward Pharma saw a inflow of $85.36M from investing activities till 2017 Q4.

View and download details of Forward Pharma cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q42017 Q22016 Q42016 Q32016 Q22016 Q12015 Q4
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow-------
Net Increase (Decrease) in Assets Liabilities-1.18M-5.61M5.72M2.11M5.88M--0.91M
Cash From (used in) Discontinued Operations-------
Other Adjustments Net-243.58M3.44M14.59M13.95M10.28M7.85M3.08M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment---0.03M-0.02M-0.02M-0.02M-0.38M
Acquisition Disposition of Subsidiaires-------
Increase (Decrease) in Investments85.36M-41.2M3.88M--43.41M
Other Cash Inflow (Outflow) from Investment Activities-------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares-24.76M------
Issuance (Repayment) of Debt Securities-------
Increase (Decrease) in Bank & Other Borrowings-------
Payment of Dividends & Other Cash Distributions-1.09B------
Other Cash from (used by) Financing Activities-------
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash145.03M87.43M-1.55M----1.13M
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year52.26M2.95M-----
Cash & Equivalents at Year End109.55M1.36B57.89M29.21M36.65M43.88M52.26M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Forward Pharma stock price history provides insight into historical stock price fluctuations, and Forward Pharma stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Forward Pharma had a Net Change in Cash and Cash Equivalents of $51.65M in the latest quarter 2017 Q4. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Forward Pharma stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Forward Pharma increased its cash from operating activities to $939.94M till 2017 Q4. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $85.36M for FWP stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. Forward Pharma spent $-1.12B from financing activities,in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For Forward Pharma Cash Flow

Quarterly Cash Flow Statements For Forward Pharma A/S Peers

Adamis Pharma cash flow, Celgene cash flow, Fennec Pharma cash flow, H. Lundbeck cash flow, Sanofi cash flow